drugset / Trial / NCT06870500

Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient

NCT06870500

Recruiting 50 enrolled South Valley University
RandomizedParallel-groupOpen-labelTreatment

Summary

Psoriasis is a chronic, immune-mediated, multisystemic, inflammatory disease caused by the interaction of multiple susceptibility genes and environmental factors that affects 1-3% of the population worldwide .Psoriasis also is a chronic inflammatory skin disease characterized by scaly indurated erythema. Psoriatic arthritis (PsA) is an autoimmune and chronic musculoskeletal disorder that is associated with psoriasis of the skin . Its presentation can vary from subtle manifestations to highly destructive forms. Joint pain, stiffness and swelling are the most common symptoms.

Timeline

Start
2025-03-05
Primary completion
2026-03-01
Completion
2026-03-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule

Indications